AskGene Pharma is a developer of prodrugs for oncology, ophthalmology, and autoimmune disease treatment. It develops cytokine fusion molecules, including antibody-cytokine prodrug fusion molecules, which selectively modulate a subset of immune cells in the tumor microenvironment, cytokine fusion molecules for addressing autoimmune diseases and inflammation disorders, as well as bifunctional molecules addressing wet age-related macular degeneration and diabetic macular edema.